These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 28624227)
1. Efficient SMN Rescue following Subcutaneous Tricyclo-DNA Antisense Oligonucleotide Treatment. Robin V; Griffith G; Carter JL; Leumann CJ; Garcia L; Goyenvalle A Mol Ther Nucleic Acids; 2017 Jun; 7():81-89. PubMed ID: 28624227 [TBL] [Abstract][Full Text] [Related]
2. Combinatorial treatment for spinal muscular atrophy: An Editorial for 'Combined treatment with the histone deacetylase inhibitor LBH589 and a splice-switch antisense oligonucleotide enhances SMN2 splicing and SMN expression in Spinal Muscular Atrophy cells' on page 264. Poletti A; Fischbeck KH J Neurochem; 2020 Apr; 153(2):146-149. PubMed ID: 32056234 [TBL] [Abstract][Full Text] [Related]
3. LNA/DNA mixmer-based antisense oligonucleotides correct alternative splicing of the SMN2 gene and restore SMN protein expression in type 1 SMA fibroblasts. Touznik A; Maruyama R; Hosoki K; Echigoya Y; Yokota T Sci Rep; 2017 Jun; 7(1):3672. PubMed ID: 28623256 [TBL] [Abstract][Full Text] [Related]
4. Combined treatment with the histone deacetylase inhibitor LBH589 and a splice-switch antisense oligonucleotide enhances SMN2 splicing and SMN expression in Spinal Muscular Atrophy cells. Pagliarini V; Guerra M; Di Rosa V; Compagnucci C; Sette C J Neurochem; 2020 Apr; 153(2):264-275. PubMed ID: 31811660 [TBL] [Abstract][Full Text] [Related]
5. Combination of valproic acid and morpholino splice-switching oligonucleotide produces improved outcomes in spinal muscular atrophy patient-derived fibroblasts. Farrelly-Rosch A; Lau CL; Patil N; Turner BJ; Shabanpoor F Neurochem Int; 2017 Sep; 108():213-221. PubMed ID: 28389270 [TBL] [Abstract][Full Text] [Related]
6. Combination of SMN trans-splicing and a neurotrophic factor increases the life span and body mass in a severe model of spinal muscular atrophy. Shababi M; Glascock J; Lorson CL Hum Gene Ther; 2011 Feb; 22(2):135-44. PubMed ID: 20804424 [TBL] [Abstract][Full Text] [Related]
7. ZPR1 prevents R-loop accumulation, upregulates SMN2 expression and rescues spinal muscular atrophy. Kannan A; Jiang X; He L; Ahmad S; Gangwani L Brain; 2020 Jan; 143(1):69-93. PubMed ID: 31828288 [TBL] [Abstract][Full Text] [Related]
16. NCALD Antisense Oligonucleotide Therapy in Addition to Nusinersen further Ameliorates Spinal Muscular Atrophy in Mice. Torres-Benito L; Schneider S; Rombo R; Ling KK; Grysko V; Upadhyay A; Kononenko NL; Rigo F; Bennett CF; Wirth B Am J Hum Genet; 2019 Jul; 105(1):221-230. PubMed ID: 31230718 [TBL] [Abstract][Full Text] [Related]
17. Identification of a Peptide for Systemic Brain Delivery of a Morpholino Oligonucleotide in Mouse Models of Spinal Muscular Atrophy. Shabanpoor F; Hammond SM; Abendroth F; Hazell G; Wood MJA; Gait MJ Nucleic Acid Ther; 2017 Jun; 27(3):130-143. PubMed ID: 28118087 [TBL] [Abstract][Full Text] [Related]
18. hnRNP M facilitates exon 7 inclusion of SMN2 pre-mRNA in spinal muscular atrophy by targeting an enhancer on exon 7. Cho S; Moon H; Loh TJ; Oh HK; Cho S; Choy HE; Song WK; Chun JS; Zheng X; Shen H Biochim Biophys Acta; 2014; 1839(4):306-15. PubMed ID: 24533984 [TBL] [Abstract][Full Text] [Related]
19. Splicing of a critical exon of human Survival Motor Neuron is regulated by a unique silencer element located in the last intron. Singh NK; Singh NN; Androphy EJ; Singh RN Mol Cell Biol; 2006 Feb; 26(4):1333-46. PubMed ID: 16449646 [TBL] [Abstract][Full Text] [Related]
20. In Vitro Evaluation of Antisense-Mediated Exon Inclusion for Spinal Muscular Atrophy. Touznik A; Maruyama R; Yokota T Methods Mol Biol; 2018; 1828():439-454. PubMed ID: 30171558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]